Downloads

For more information about Abpro, feel free to download the following materials:

Production of Superior Anti-Idiotypic Monoclonal Antibodies

This white paper is an example of a panel of hybridomas which were developed by Abpro's HTP^TM Platform that neutralizes ligand binding.  Developing anti-idiotype antibodies is a specialty for Abpro's HTP^TM platform which boasts with a 100% success rate on anti-idiotype projects.

Nature Paper Validating Abpro's Antibody

Abpro developed a therapeutic mAb candidate that was recently featured in Nature.